Windtree Therapeutics(WINT) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates WARRINGTON, PA – August 20, 2024 – Windtree Therapeutics, Inc. ("Windtree" or "the Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the second quarter ended June 30, 2024 and provided key business updates. "The second quarter of 2024 was marked with significant progres ...